Literature DB >> 20497252

Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa.

A B M Kharsany1, N Hancock, J A Frohlich, H R Humphries, S S Abdool Karim, Q Abdool Karim.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the HIV-1 RNA pooled nucleic acid amplification testing (NAAT) strategy to screen pregnant women in the 'window period' of acute HIV infection (AHI) in rural South Africa.
METHODS: In 2007 and 2008, 750 consecutive pregnant women on their first antenatal care visit to a primary health care clinic were tested anonymously for HIV infection. HIV-1 RNA pooled NAAT was performed on HIV antibody-negative samples. All positive pools were tested individually and positive samples were classified as incident cases to calculate HIV incidence.
RESULTS: The overall HIV prevalence was 37.3% [95% confidence interval (CI) 34.3–41.3]. Of the 467 HIV antibody-negative samples, four (0.9%) were HIV-1 RNA-positive. The mean viral load in the four samples was 386 260 HIV-1 RNA copies/mL (range 64 200–1 228130). The HIV incidence was 11.2%per year (95% CI 0.3–22.1) and all women with AHI were 21 years of age.
CONCLUSIONS: Identifying AHI in pregnancy is important for health interventions to reduce perinatal and heterosexual transmission of HIV, and to estimate HIV incidence for epidemiological surveillance. © British HIV Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497252      PMCID: PMC2965267          DOI: 10.1111/j.1468-1293.2010.00838.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  17 in total

Review 1.  Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.

Authors:  J Steven McDougal; Christopher D Pilcher; Bharat S Parekh; Guy Gershy-Damet; Bernard M Branson; Kimberly Marsh; Stefan Z Wiktor
Journal:  AIDS       Date:  2005-05       Impact factor: 4.177

2.  Rapid, real-time detection of acute HIV infection in patients in Africa.

Authors:  Susan A Fiscus; Christopher D Pilcher; William C Miller; Kimberly A Powers; Irving F Hoffman; Matthew Price; David A Chilongozi; Clement Mapanje; Robert Krysiak; Syze Gama; Francis E A Martinson; Myron S Cohen
Journal:  J Infect Dis       Date:  2006-12-22       Impact factor: 5.226

3.  National HIV incidence measures--new insights into the South African epidemic.

Authors:  Thomas Rehle; Olive Shisana; Victoria Pillay; Khangelani Zuma; Adrian Puren; Warren Parker
Journal:  S Afr Med J       Date:  2007-03

4.  Clinical presentation and diagnosis of primary HIV-1 infection.

Authors:  Eric S Daar; Christopher D Pilcher; Frederick M Hecht
Journal:  Curr Opin HIV AIDS       Date:  2008-01       Impact factor: 4.283

Review 5.  "Know your epidemic, know your response": a useful approach, if we get it right.

Authors:  David Wilson; Daniel T Halperin
Journal:  Lancet       Date:  2008-08-05       Impact factor: 79.321

6.  Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study.

Authors:  Ronald H Gray; Xianbin Li; Godfrey Kigozi; David Serwadda; Heena Brahmbhatt; Fred Wabwire-Mangen; Fred Nalugoda; Mohamed Kiddugavu; Nelson Sewankambo; Thomas C Quinn; Steven J Reynolds; Maria J Wawer
Journal:  Lancet       Date:  2005-10-01       Impact factor: 79.321

7.  Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.

Authors:  Christopher D Pilcher; J Todd McPherson; Peter A Leone; Marlene Smurzynski; Judy Owen-O'Dowd; Amy L Peace-Brewer; Juanita Harris; Charles B Hicks; Joseph J Eron; Susan A Fiscus
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

8.  Identification of primary HIV-1C infection in Botswana.

Authors:  V Novitsky; E Woldegabriel; C Wester; E McDonald; R Rossenkhan; M Ketunuti; J Makhema; G R Seage; M Essex
Journal:  AIDS Care       Date:  2008-08

9.  Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.

Authors:  Pragna Patel; Duncan Mackellar; Pat Simmons; Apurva Uniyal; Kathleen Gallagher; Berry Bennett; Timothy J Sullivan; Alexis Kowalski; Monica M Parker; Marlene LaLota; Peter Kerndt; Patrick S Sullivan
Journal:  Arch Intern Med       Date:  2010-01-11

10.  Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection.

Authors:  Christopher D Pilcher; George Joaki; Irving F Hoffman; Francis E A Martinson; Clement Mapanje; Paul W Stewart; Kimberly A Powers; Shannon Galvin; David Chilongozi; Syze Gama; Matthew A Price; Susan A Fiscus; Myron S Cohen
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

View more
  21 in total

1.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

2.  Postpartum family planning service provision in Durban, South Africa: client and provider perspectives.

Authors:  Heather M Marlow; Suzanne Maman; Dhayendre Moodley; Siân Curtis
Journal:  Health Care Women Int       Date:  2013-09-02

3.  Missed Opportunities for Preventing Perinatal Transmission of Human Immunodeficiency Virus, Florida, 2007-2014.

Authors:  Mary Jo Trepka; Soumyadeep Mukherjee; Consuelo Beck-Sagué; Lorene M Maddox; Kristopher P Fennie; Diana M Sheehan; Maithri Prabhakar; Dan Thompson; Spencer Lieb
Journal:  South Med J       Date:  2017-02       Impact factor: 0.954

4.  Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial.

Authors:  Kathryn Therese Mngadi; Silvia Maarschalk; Anneke C Grobler; Leila E Mansoor; Janet A Frohlich; Bernadette Madlala; Nelisiwe Ngcobo; Salim S Abdool Karim; Quarraisha Abdool Karim
Journal:  AIDS Behav       Date:  2014-05

5.  Association of recent HIV infection and in-utero HIV-1 transmission.

Authors:  Taha E Taha; Maria M James; Donald R Hoover; Jin Sun; Oliver Laeyendecker; Caroline E Mullis; Johnstone J Kumwenda; Jairam R Lingappa; Bertran Auvert; Charles S Morrison; Lynne M Mofensen; Allan Taylor; Mary G Fowler; Newton I Kumenda; Susan H Eshleman
Journal:  AIDS       Date:  2011-07-17       Impact factor: 4.177

6.  Field performance of the INSTI HIV-1/-2 antibody test in two South African antenatal clinics.

Authors:  Simnikiwe H Mayaphi; Desmond J Martin; Thomas C Quinn; Anton C Stoltz
Journal:  J Med Virol       Date:  2019-03-18       Impact factor: 2.327

7.  Differences in Risk Behavior and Demographic Factors Between Men Who Have Sex With Men With Acute and Nonacute Human Immunodeficiency Virus Infection in a Community-Based Testing Program in Los Angeles.

Authors:  Dvora Joseph Davey; Matthew Beymer; Chelsea P Roberts; Robert K Bolan; Jeffrey D Klausner
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

Review 8.  Antiretrovirals and safer conception for HIV-serodiscordant couples.

Authors:  Lynn T Matthews; Jennifer A Smit; Susan Cu-Uvin; Deborah Cohan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

Review 9.  Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.

Authors:  Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

10.  Prevalence of undiagnosed acute and chronic HIV in a lower-prevalence urban emergency department.

Authors:  Phillip C Moschella; Kimberly W Hart; Andrew H Ruffner; Christopher J Lindsell; D Beth Wayne; Matthew I Sperling; Alexander T Trott; Carl J Fichtenbaum; Michael S Lyons
Journal:  Am J Public Health       Date:  2014-07-17       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.